摘要：Chemotherapy related toxicities have been the major factor limiting the success of acute lymphoblastic leukemia (ALL) induction therapy. Several factors, including the pharmacogenetics of asparaginase and anthracyclines, could contribute to difference in treatment outcome in ALL. We investigated the significance of variations in genes involved in hepatic and cardiac toxicity in acute lymphoblastic leukemia (ALL). Genotyping of
SOD2 (rs4880),
PNPL3 (rs738409) and
ABCC1 (rs4148350), C
BR1 (rs9024) and
ABCG2 (rs2231142) was performed by Tetra-ARMS PCR-based technique to evaluate the genotype–phenotype correlation. Our results showed only minor allele G of
SOD2 rs4880 increase the risk of hepatic toxicity [OR 2.63 (1.42–4.84),
P = < 0.05
